Šajā tīmekļa vietnē tiek izmantotas sīkdatnes. Turpinot lietot šo vietni, jūs piekrītat sīkdatņu izmantošanai. Uzzināt vairāk.
Teksta versija
LEGAL ACTS OF THE REPUBLIC OF LATVIA
home
 
The translation of this document is outdated.
Translation validity: 05.11.2020.–31.05.2021.
Amendments not included: 29.04.2021.
Text consolidated by Valsts valodas centrs (State Language Centre) with amending laws of:

4 March 1999 [shall come into force from 26 March 1999];
11 November 1999 [shall come into force from 1 January 2000];
8 June 2000 [shall come into force from 11 July 2000];
9 May 2002 [shall come into force from 12 June 2002];
24 October 2002 [shall come into force from 27 November 2002];
12 December 2002 [shall come into force from 3 January 2002];
15 February 2007 [shall come into force from 24 February 2007];
17 May 2007 [shall come into force from 13 June 2007];
15 May 2008 [shall come into force from 11 June 2008];
16 June 2009 [shall come into force from 1 July 2009];
19 November 2009 [shall come into force from 23 December 2009];
21 October 2010 [shall come into force from 1 January 2011];
13 October 2011 [shall come into force from 1 January 2012];
1 December 2011 [shall come into force from 1 January 2012];
26 July 2012 [shall come into force from 16 August 2012];
14 February 2013 [shall come into force from 23 February 2013];
25 April 2013 [shall come into force from 16 May 2013];
19 June 2014 [shall come into force from 11 July 2014];
14 May 2015 [shall come into force from 1 June 2015];
29 October 2015 [shall come into force from 3 December 2015];
28 January 2016 [shall come into force from 1 March 2016];
7 April 2016 [shall come into force from 1 May 2016];
9 February 2017 [shall come into force from 17 March 2017];
8 June 2017 [shall come into force from 1 Jaunary 2018];
21 September 2017 [shall come into force from 16 October 2017];
6 December 2018 [shall come into force from 10 January 2019];
26 September 2019 [shall come into force from 8 October 2019];
21 November 2019 [shall come into force from 23 November 2019];
11 June 2020 [shall come into force from 6 July 2020];
3 September 2020 [shall come into force from 29 September 2020];
17 September 2020 [shall come into force from 5 November 2020].

If a whole or part of a section has been amended, the date of the amending law appears in square brackets at the end of the section. If a whole section, paragraph or clause has been deleted, the date of the deletion appears in square brackets beside the deleted section, paragraph or clause.

The Saeima1 has adopted and
the President has proclaimed the following law:

On the Procedures for the Coming into Force and Application of the Criminal Law

[24 October 2002]

Section 1. It is determined that the Criminal Law shall come into force on 1 April 1999.

Section 2. (1) Criminal proceedings in pre-trial investigation offices and in the courts, regarding offences under Sections 77 and 79; Section 112, Paragraphs one and two; Section 112.1, Paragraph one; Section 134, Paragraph one and Sections 134.1, 145.1, 149, 149.3, 150.2, 150.5, 161.10, 179, 180, 194.2, 195.1, 195.2, 195.3, 196, 209.1 and 211 of the Criminal Code of Latvia, shall be terminated.

(2) The criminal proceedings in the proceedings of pre-trial investigating institutions and in courts, which are qualified on the basis of Section 253 of the Criminal Law (17 June 1998 version with amendments made by amending laws of 18 May 2000 and 24 April 2002), regarding illegal activity with narcotic and psychotropic substances - the manufacture, acquisition, storage and transportation thereof, shall be terminated if in accordance with Annex 2 to this Law such are recognised as committed on a small scale.

[24 October 2002]

Section 3. The criminal proceedings in the proceedings of pre-trial investigating institutions regarding offences listed in Section 2 of this Law shall be terminated by a decision of a prosecutor.

Section 4. The criminal proceedings in the proceedings of courts regarding offences referred to in Section 2 of this Law shall be terminated by a decision of a court taken in a court procedural hearing or a court hearing.

Section 5. Persons who, prior to the Criminal Law coming into force, have been convicted of criminal offences, which in accordance with the Criminal Law are not considered criminal offences, that is, for offences, which are referred to in Section 2 of this Law, shall be released from serving the basic punishment and additional punishment.

Section 6. Persons specified in Section 5 of this Law shall, on the basis of a submission of the institution by which the judgment is to be executed, be released from their punishment by the district (city) court for the place where the punishment is being served, in accordance with the procedures of Section 374 of the Criminal Procedure Code of Latvia. Persons, the judgment for whom has not been given for execution, shall be released from their punishment by the court, in accordance with the procedures of Section 373 of the Criminal Procedure Code of Latvia.

Section 7. The court may set aside the criminal record of persons who are released from serving their punishment in accordance with Section 5 of this Law, as well as of persons who have already served their punishment or who have been released before the expiration of the term of their punishment, on the basis of a submission by such persons, if such persons have been convicted of offences referred to in Section 2 of this Law and their criminal record has not been extinguished.

Section 8. Judgments shall be amended for persons who have been convicted according to the sections referred to in Section 2 of this Law and also other sections of the Criminal Code of Latvia, taking into account that such persons shall be released from all types of punishments imposed on them for the offences referred to in Section 2 of this Law.

Section 9. Cases regarding amending of a judgment for persons who have been convicted for the offences referred to in Section 2 of this Law, as well as for other offences, shall be adjudicated by the relevant court of the same designation [district (city), regional] in accordance with the procedures provided for in Section 6 of this Law.

Section 10. (1) Punishments shall be reduced to the maximum provided for in the relevant section of the Criminal Law, as to persons which have been convicted according to sections of the Criminal Code of the Latvian S.S.R. or the Criminal Code of Latvia, which are not referred to in Section 2 of this Law and who are serving a punishment, if the punishment imposed by the court is more severe than the maximum punishment provided for in the relevant section of the Criminal Law.

(2) Punishments shall be reduced to maximum punishment provided for in Section 253 or 253.1 of the Criminal Law for persons who have been convicted for illegal activities with especially dangerous narcotic or psychotropic substances, if such have not been committed on a small scale and if the punishment imposed by the court is more severe than the maximum punishment provided for in the relevant section of the Criminal Law.

[24 October 2002]

Section 11. Matters regarding reduction of punishment as to persons referred to in Section 10 of this Law shall be adjudicated by the relevant court of the same designation [district (city), regional] in accordance with the procedures provided for in Section 6 of this Law.

Section 12. Confiscation of property shall not be applied to persons referred to in Sections 5 and 10 of this Law if at the time this Law comes into force the part of the judgment concerning confiscation of property has not been carried out, the property has not been taken and the relevant section of the Criminal Law does not provide for confiscation of property.

Section 13. Persons convicted prior to the Criminal Law coming into force shall serve the punishment imposed according to the relevant section of the Criminal Code of the Latvian S.S.R. or the Criminal Code of Latvia, except in the cases referred to in Sections 5 and 10 of this Law.

Section 14. The provisions of Sections 10 and 12 of this Law shall not apply to persons who are especially dangerous recidivists and who have been convicted of offences according to the phrase "if such is committed by an especially dangerous recidivist", as provided for in sections of the Criminal Code of the Latvian S.S.R. or of the Criminal Code of Latvia.

Section 15. The type of punishment provided for in Section 72, Section 72.1, Paragraph two, Section 99, Clauses 1, 2, 5, 6, 7, 9 (except murder if committed by a person serving a life imprisonment) and 10, Section 121, Paragraph four and Section 214.2, Paragraph three of the Criminal Code of Latvia - the death penalty - shall not be applied from the time this Law comes into force.

Section 15.1

[1 December 2011]

Section 16. Persons who, prior to the Criminal Law coming into force, have been convicted by the application of Section 43.1 of the Criminal Code of Latvia with deprivation of liberty, that is, with a conditional punishment, and regarding whom the term of the conditional punishment has not expired, shall be deemed to have a suspended sentence with a probationary period until the expiry of the referred to time period.

Section 17. Persons, who prior to the coming into force of the Criminal Law have committed criminal offences for which criminal liability is provided for under sections of the Criminal Code of Latvia, except for the offences referred to in Section 2 of this Law, shall be held criminally liable and punished under the Criminal Code of Latvia, therewith taking into consideration that criminal liability may not come into effect if the relevant section of the Criminal Law does not contain those elements of the criminal offence which are set out in the section of the Criminal Code of Latvia.

Section 18. The provisions of Sections 10, 12, 13 and 17 of this Law shall not apply to persons, who, prior to the coming into force of the Criminal Law, have committed a crime provided for in Sections 139, 141, 142 and 144 of the Criminal Code of Latvia, that is, have committed theft, fraud or misappropriation, including on a small scale, or an assault for the purpose of robbery with the intent to gain property, if the property was not stolen.

Section 19. Persons, who have committed separate criminal offences (including continuous and continuing criminal offences) provided for in the Criminal Law and which were commenced prior to the coming into force of the Criminal Law, but were completed or terminated afterwards, shall be held criminally liable and punished in accordance with the relevant section of the Criminal Law.

Section 19.1 Stealing of movable property shall be deemed a completed criminal offence from the moment when a person has obtained it illegally, regardless of whether the person had had an opportunity of acting with the relevant property as his or her own.

[15 May 2008]

Section 19.2 (1) A misdemeanour shall be an offence that has resulted in property loss which at the time of committing the criminal offence has been less than half of the minimum monthly salary specified in the Republic of Latvia at that time, or the endangering of the interests protected by law caused thereby is small.

(2) Such criminal offence provided for in Section 221.6 of the Criminal Law shall be recognised as a misdemeanour which has been committed without exceeding the following quantities of tobacco products:

1) 20 cigarettes;

2) 10 cigarillos;

3) 5 cigars;

4) 30 grams of smoking, heated tobacco, snuff or chewing tobacco or tobacco leaves, tobacco products for oral use or other tobacco products.

[11 June 2020; 3 September 2020]

Section 20. Liability for an offence, provided for in the Criminal Law, which has been committed on a large scale, shall apply if the total value of the property which was the object of the offence was not less than the total of fifty minimum monthly salaries specified in the Republic of Latvia at that time. The value of the property shall be determined according to the market prices or prices equivalent thereto at the time when the offence was committed.

[1 December 2011]

Section 20.1 (1) Liability for the offence provided for in Sections 190, 191, and 221 (in relation to alcohol or other alcoholic beverages), and also Sections 221.1 and 221.2 of the Criminal Law which has been committed on a large scale shall apply if the quantity of alcoholic beverage reaches 20 litres of absolute alcohol.

(2) Liability for the criminal offence provided for in Sections 190, 191, and 221 of the Criminal Law (in relation to tobacco products) which has been committed on a large scale shall apply if the quantity of tobacco products reaches:

1) 25 000 cigarettes;

2) 12 500 cigarillos;

3) 6250 cigars;

4) 6250 grams of smoking, heated tobacco, snuff or chewing tobacco or tobacco leaves, tobacco products for oral use or other tobacco products.

[19 November 2009; 25 April 2013; 3 September 2020]

Section 21. The provisions of Section 20 of this Law shall not apply to the qualification of the offence provided for in Section 190.1, Paragraph two, Section 253, Paragraph two and Section 253.1, Paragraph three of the Criminal Law, if such has been committed on a large scale.

[24 October 2002]

Section 22. (1) Liability for a criminal offence provided for in the Criminal Law which has been committed on a small scale shall apply if the offender had the intention to acquire property which was the object of a criminal offence, the value of which at the time when the offence was committed did not exceed one minimum monthly salary as specified in the Republic of Latvia at that time. The value of the property shall be determined according to the market prices or prices equivalent thereto at the time when the offence was committed.

(2) Liability for a criminal offence provided for in Section 221.6 of the Criminal Law which has been committed on a small scale shall apply if the quantity of tobacco products is lower than the quantity laid down in Section 23.1, Paragraph three of this Law.

[29 October 2015; 3 September 2020]

Section 22.1 The provisions of Section 22 of this Law shall not apply to the qualification of the criminal offence provided for in Section 253.2 of the Criminal Law, if such has been committed on a small scale.

[24 October 2002]

Section 23. (1) Liability for a criminal offence provided for in the Criminal Law causing substantial harm shall apply if due to the criminal offence any of the following consequences have set in:

1) property loss has been suffered which at the time of committing the criminal offence has not been less than the total of five minimum monthly salaries specified in the Republic of Latvia at that time, and also other interests protected by law have been threatened;

2) property loss has been suffered which at the time of committing the criminal offence has not been less than the total of ten minimum monthly salaries specified in the Republic of Latvia at that time;

3) other interests protected by law have been significantly threatened.

(2) [29 October 2015].

(3) The criteria for endangering of the interests protected by law resulting from criminal offences may be specified in annexes to this Law.

[8 June 2000; 9 May 2002; 25 April 2013; 29 October 2015]

Section 23.1 (1) Liability for a criminal offence provided for in the Criminal Law, which has been committed on a significant scale, shall apply if the total value of the property which was the object of the criminal offence was not less than the total of ten minimum monthly salaries specified in the Republic of Latvia at that time. The value of the property shall be determined according to the market prices or prices equivalent thereto at the time when the offence was committed.

(2) Liability for a criminal offence provided for in Sections 190, 191, and 221 (in relation to alcohol or other alcoholic beverages) and Sections 221.1 and 221.2 of the Criminal Law which has been committed on a significant scale shall apply if the quantity of alcoholic beverage reaches 10 litres of absolute alcohol.

(3) Liability for a criminal offence provided for in Sections 190, 191, and 221 of the Criminal Law (in relation to tobacco products) which has been committed on a significant scale shall apply if the quantity of tobacco products reaches:

1) 5000 cigarettes;

2) 2500 cigarillos;

3) 1250 cigars;

4) 1250 grams of smoking, heated tobacco, snuff or chewing tobacco or tobacco leaves, tobacco products for oral use or other tobacco products.

[29 October 2015; 3 September 2020]

Section 24. (1) Liability for a criminal offence provided for in the Criminal Law that has caused serious consequences shall apply if the criminal offence has resulted in death of a person, serious bodily injuries to at least one person, moderate bodily injuries to a number of persons have been caused, or property loss which was not less than the total of fifty minimum monthly salaries specified in the Republic of Latvia at that time has been inflicted, or other serious harm has been caused to the interests protected by law.

(2) The criteria for the specification of the level of seriousness of bodily injury are provided for in annexes to this Law.

(3) Liability for the criminal offence provided for in Section 193.2 of the Criminal Law that has caused serious consequences shall apply if the gained profit, the prevented losses, the total scope of the submitted orders, the value of the used financial instruments or spot commodity contracts, or the total amount of the used means at the time of committing the criminal offence exceeds the total of fifty minimum monthly salaries specified in the Republic of Latvia at that time.

[24 October 2002; 25 April 2013; 29 October 2015; 28 January 2016; 8 June 2017]

Section 24.1 Torturing shall mean intentional repeated or continuous act or failure to act of a person, causing strong physical pain or mental suffering to another person, or intentional extraordinary act or failure to act of a person, causing strong physical pain or mental suffering to another person in order to influence his or her or another person`s consciousness or will.

[19 November 2009; 29 October 2015]

Section 24.2 The property not to be confiscated for the convicted person or his or her dependants is specified in Annex 4 to this Law.

[25 April 2013]

Section 25. Upon the coming into force of the Criminal Law, the Criminal Code of Latvia is repealed.

Transitional Provisions

[4 March 1999]

1. The type of punishment - custodial arrest - as provided for in the Criminal Law, shall not be imposed until 1 January 2015. This condition shall not be applicable in cases when the court applies the punishment provided for in the sections of Chapter XXV of the Criminal Law to a military person. Persons for whom the court replaces or has replaced up the day of the coming into force of such condition the punishment not served - community service or a fine - with custodial arrest, shall serve it partly in a closed prison at the medium level of serving the punishment regime.

[9 May 2002; 12 December 2002; 15 February 2007; 16 June 2009; 19 November 2009]

2. [12 December 2002]

3. [24 October 2002]

4. For criminal offences that have been committed until 31 December 2017 the level of seriousness of bodily injury inflicted shall be determined in accordance with the law in force by 31 December 2017.

[8 June 2017]

Informative Reference to European Union Directives

[28 January 2016]

This Law contains legal norms arising from:

1) Directive 2008/99/EC of the European Parliament and of the Council of 19 November 2008 on the protection of the environment through criminal law;

2) Directive 2014/57/EC of the European Parliament and of the Council of 16 April 2014 on criminal sanctions for market abuse (market abuse directive).

This Law shall come into force on the day following its proclamation.

This Law has been adopted by the Saeima on 15 October 1998.

President G. Ulmanis

Rīga, 4 November 1998.

 

Law On the Procedures for the Coming into Force and Application of the Criminal Law
Annex 1

Criteria for Determination of Danger or Significant Danger to the Interests Protected by Law for the Preservation of the Forest Environment

[25 April 2013]

1. Interests protected by law for the preservation of the forest environment shall be endangered:

1) if in one or more forest stand or one or more parts thereof (a part of a forest stand is 0.1 hectares or larger area, in specially protected territories - 0.05 hectares or larger area) an area of 0.5 hectares has been destroyed, but in one or more forest stands the age of which is at least 10 years less that the age of the final felling, or in one or more of the parts thereof an area of 0.2 hectares or more has been destroyed;

2) if in one or more forest stands the age of which is at least 10 years less that the age of the final felling, or in one or more of the parts thereof an area of 1 hectare or more has been damaged in such an amount as the basal area has become at least 30 per cent less than the minimum basal area;

3) if in one or more forest stands in which clear felling has been prohibited, in one or more of the parts thereof an area of 0.2 hectares or more has been destroyed;

4) if in one or more forest stands in which final felling has been prohibited, in one or more of the parts thereof has been damaged in such an amount as the basal area of 0.2 hectares or more has become at least 30 per cent less than the minimum basal area. Exceptions are the cases referred to in Section 9, Paragraph two, Clauses 1 and 2 of the Law on Forests;

5) if in one or more forest stands in which economic activity has been prohibited, in one or more of the parts thereof an area of 0.1 hectares or more has been damaged;

6) in other cases, if there is an opinion regarding endangerment to the interests protected by law for the preservation of the forest environment.

2. Paragraph 1, Sub-paragraphs 1, 2 and 3 shall not apply to forest stands where the dominant species is white alder.

3. Endangerment to the interests protected by law for the preservation of the forest environment shall be taken into account if the size of the area damaged or destroyed referred to in Paragraph 1, Sub-paragraphs 1, 2, 3, 4 and 5 of this Annex has been exceeded at least two times.

4. An opinion regarding endangerment or significant endangerment to the interests protected by law for the preservation of the forest environment shall be prepared by the territorial office of the State Forestry Service in which the supervised territory the criminal offence has been committed.

 

Law On the Procedures for the Coming into Force and Application of the Criminal Law
Annex 2

[25 April 2013]

Criteria for the Measurement Amounts of Illegally Traded Narcotic and Psychotropic Substances and Medicinal Products, as well as Substances, which May be Utilised for Illegal Manufacture of Narcotic and Psychotropic Substances (Precursors)

[24 October 2002; 19 November 2009; 21 October 2010; 13 October 2011; 1 December 2011; 26 July 2012; 14 February 2013; 19 June 2014; 14 May 2015; 7 April 2016; 9 February 2017; 21 September 2017; 6 December 2018; 26 September 2019; 21 November 2019; 17 September 2020]

I. General Provisions

1. The measurement amounts of narcotic plants, substances and medicinal products included in the list of narcotic substances, psychotropic substances and precursors controlled in Latvia (hereinafter - Schedules I, II, and III), as well as precursors included in Annex I to Regulation (EC) No 273/2004 of the European Parliament and of the Council of 11 February 2004 on drug precursors and Annex to Council Regulation (EC) No 111/2005 of 22 December 2004 laying down rules for the monitoring of trade between the Community and third countries in drug precursors (hereinafter - Schedule IV) are established, taking into account the harm of illegally trafficked narcotic and psychotropic substances to human health and the level of danger in conformity with Schedules I, II, III and IV:

1) Schedule I (prohibited especially dangerous narcotic substances, equivalent psychotropic substances and plants, which endanger health, if illegally trafficked and used);

2) Schedule II (very dangerous narcotic substances and equivalent psychotropic substances permitted for medical and scientific purposes);

3) Schedule III (dangerous psychotropic substances which might be abused);

4) Schedule IV (substances which may be utilised for unauthorised manufacture of narcotic and psychotropic substances (precursors)).

2. The established amounts of substances shall also apply to:

1) isomers, structural analogues, active metabolites, esters, ethers and salts of the substances included in Schedules I, II, and III, and also to salts of isomers, structural analogues, active metabolites, esters and ethers;

2) medicinal products which contain the substances included in Schedules II and III;

3) substance derivatives with a similar pharmacological effect;

4) stereoisomers and salts of the substances included in Paragraph 14 of Schedule IV, except for cathine and cathine salts, as well as salts of the substances included in Paragraphs 15 and 16, except for hydrochloric acid and sulphuric acid salts.

3. The established amount of substance shall be calculated in any medicinal product form, mixture of substances, liquid, extract, infusion, and brew irrespective of the amount of impurities produced during the substance manufacturing process.

3.1 If a substance listed in Chapter III, IV or V of this Annex is also a part of the psychotropic substances and their compounds referred to in Chapter II, Chapter II shall not apply to this substance.

II. Substances and Plants Included in Schedule I (prohibited especially dangerous narcotic substances and equivalent psychotropic substances which endanger health, if illegally trafficked and used)

4. Synthetic opioid analgesics classified in conformity with the Single Convention on Narcotic Drugs of 30 March 1961:

No.

International non-propriety name of the substance (INN)/trivial name of the substance

Number in the Chemical Abstracts Service (hereinafter - CAS No.)

Chemical name of the substance

Amount up to which the quantity is recognised as small

Amount from which the quantities are recognised as large

1)

alphacetylmethadol (INN) 1553-31-7 [(3R*,6R*)-6-dimethylamino-4,4-di(phenyl)heptan-3-yl] acetate

0.1 g

1 g

2)

MPPP, desmethylprodine 13147-09-6 (4-phenyl-1-methylpiperidine-4-yl)propanoate

0.1 g

1 g

3)

PEPAP 64-52-8 4-phenyl-1-(2-phenylethyl)piperidine-4-yl acetate

0.1 g

1 g

4)

AH-7921 55154-30-8 3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide

0.1 g

1 g

5)

U-47700 82657-23-6 3,4-dichloro-N-[(1R,2R)-2-(dimethylamino)cyclohexyl]-N-methylbenzamide

0.1 g

1 g

6)

U-51754 121279-74-1 2-(3,4-dichlorophenyl)-N-[2-(dimethylamino)cyclohexyl]-N-methyl-acetamide

0.1 g

1 g

7)

3,4-methylenedioxy-U-47700 Not available N-(2-(dimethylamino)cyclohexyl)-N-methylbenzo[d][1,3]dioxol-5-carboxamide

0.1 g

1 g

8)

furanyl UF-17 Not available N-(2-(dimethylamino)cyclohexyl)-N-phenylfuran-2-carboxamide

0.1 g

1 g

9)

viminol 21363-18-8 alpha-((Bis(1-methylpropyl)amino)methyl)-((2-chlorophenyl)methyl)-1H-pyrrole-2-methanol

0.1 g

1 g

5. Morphinan derivatives classified in conformity with the Single Convention on Narcotic Drugs of 30 March 1961:

No.

International non-propriety name of the substance (INN)/trivial name of the substance

CAS No.

Chemical name of the substance

Amount up to which the quantity is recognised as small

Amount from which the quantities are recognised as large

1)

heroin, morphine diacetate (INN) 561-27-3 (5α,6α)-7,8-didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol diacetate

0.001 g

1 g

2)

desomorphine, Krokodil 427-00-9 4,5-α-epoxy-17-methylmorphinan-3-ol

0.1 g

1 g

3)

etorphine, Immobilon, M99 14521-96-1 (5alpha,7alpha)-7-(2-hydroxypentan-2-yl)-6-methoxy-17-methyl-4,5-epoxy-6,14-ethenomorphinan-3-ol

0.1 g

1 g

4)

acetorphine 25333-77-1 4,5α-epoxy-7α-(1-hydroxy-1-methylbutyl)-6-methoxy-17-methyl-6,14-endoetheno-morphinan-3-yl acetate

0.1 g

1 g

6. [21 September 2017]

7. Products of plant origin with narcotic effect classified in conformity with the Single Convention on Narcotic Drugs of 30 March 1961:

No.

Product name

Amount up to which the quantity is recognised as small

Amount from which the quantities are recognised as large

1)

raw opium

0.2 g

10 g

2)

poppy straw:    

a)

dried

20 g

500 g

b)

undried

100 g

1500 g

3)

preparations, which are manufactured from any type of poppy if they contain narcotically active opium alkaloids: morphine, codeine, thebaine (extracts, infusions and brews with active substance content in any amount):    

a)

poppy straw extract

30 ml

200 ml

b)

poppy straw concentrate

1 ml

50 ml

c)

opium, which is acquired from plant extracts

0.1 g

10 g

d)

acetylated and partially acetylated opium

0.05 g

10 g

4)

cannabis:    

a)

marijuana, undried

5 g

1 kg

b)

marijuana, dried

1 g

100 g

c)

hashish

0.1 g

50 g

d)

cannabis resin, oil, extracts and tinctures

0.05 g

20 g

e)

dried mixture of plants that contains the substance referred to in Paragraph 7, Sub-paragraph 4, Clause "b" in any proportion

1 g

100 g

f)

dried mixture of plants that contains the substances referred to in Paragraph 7, Sub-paragraph 4, Clauses "c" and "d" in any proportion

0.5 g

50 g

g)

mixture of substances that contains dronabinol (delta-9-tetrahydrocannabinol) in any amount that is not separable from the total quantity of the mixture of substances

5 g

50 g

h)

undried mixture of plants that contains the substance referred to in Paragraph 7, Sub-paragraph 4, Clause "a" in any proportion

5 g

1 kg

5)

coca leaf, dried

10 g

500 g

7.1 Narcotic substances corresponding to the description:

No.

Name of substance

Amount up to which the quantity is recognised as small

Amount from which the quantities are recognised as large

1)

Derivatives of indole, azaindole, and indazole-3-carbonyl

Derivatives of indole-3-carbonyl, derivatives of azaindol-3-carbonyl, and derivatives of indazole-3-carbonyl, which are replaced at indole, azaindole or indazole cycle in condition 1 of the nitrogen atom with a not-replaced or replaced alkyl group and in condition 3 replaced at carbonyl group with:

• a not-replaced or replaced alkyl group or a cycloalkyl group;

• a not-replaced or replaced aromatic or heteroaromatic cycle;

• a not-replaced or replaced alkoxy group, aryloxy group, heteryloxy group;

• a replaced amino group

and in the indole or azaindole cycle condition 2 not replaced or replaced with an alkyl group, and any of the abovementioned compounds, which has additionally been replaced in an indole, azaindole or indazole cycle, including such where the substitute makes an additional cycle

0.003 g

1 g

2)

Acetylfentanyl

N-(1-phenethylpiperidine-4-yl)-N-phenylacetamide and any compound which is derived from N-(1-phenethylpiperidine-4-yl)-N-phenylacetamide if one or more of the following conditions exist:

a) by replacing one or several hydrogen atoms on one or both benzene rings with one or several identical or different halogen atoms, alkyl groups, hydroxy groups or alkoxy groups;

b) by replacing one or several hydrogen atoms in the conditions 2, 3, 5 or 6 of the piperidine cycle with a not-replaced or replaced alkyl group;

c) by replacing one or several hydrogen atoms of the ethylene group with a not-replaced or replaced alkyl group or hydroxy group;

d) by replacing one or several hydrogen atoms in the acetyl group with not-replaced or replaced alkyl group(-s), alkenyl group, methoxyl group, or by including a carbon atom in a cycle which may be replaced, including, by forming supplementing cycles;

e) by replacing ethylene group with methylene group;

f) by replacing a hydrogen atom in condition 4 of the piperidine cycle with a not-replaced or replaced phenyl group or ester group;

g) by changing a benzene ring within the N-(1-phenethylpiperidine-4-yl) group with another cyclic structure, different from the benzene ring, which may be replaced;

h) by changing the benzene ring of the N-(1-phenethylpiperidine-4-yl) group with another saturated cycle that differs from the benzene ring and may be replaced

0.001 g

1 g

8. Substances and plants classified in conformity with the Convention on Psychotropic Substances of 21 February 1971:

8.1. Phenylethylamine Derivatives

No.

International non-propriety name of the substance (INN)/trivial name of the substance

CAS No.

Chemical name of the substance

Amount up to which the quantity is recognised as small

Amount from which the quantities are recognised as large

1)

mescaline 54-04-6 2-(3,4,5-trimethoxyphenyl)ethanamine

0.03 g

1 g

2)

fenethylline 3736-08-1 (RS)-1,3-dimethyl-7-[2-(1-phenylpropan-2-ylamino)ethyl]purine-2,6-dione

0.03 g

10 g

3)

fenproporex 16397-28-7 3-(1-phenylpropan-2-ylamino)propanenitrile

0.03 g

10 g

4)

phentermine 122-09-8 2-methyl-1-phenylpropan-2-amine

0.03 g

10 g

5)

mefenorex, Rondimen, Pondinil, Anexate 17243-57-1 3-chloro-N-(1-phenylpropan-2-yl)propan-1-amine

0.03 g

10 g

6)

4-methylaminorex (±)-cis isomers-29493-77-4 4-methyl-5-phenyl-4,5-dihydro-1,3-oxazol-2-amine

0.01 g

1 g

7)

4.4′-DMAR 1445569-01-6 4-methyl-5-(4-methylphenyl) 4.5-dihydro-oxazol-2-amine

0.01 g

1 g

8.2. Natural Substances and Their Derivatives

No.

International non-propriety name of the substance (INN)/trivial name of the substance

CAS No.

Chemical name of the substance

Amount up to which the quantity is recognised as small

Amount from which the quantities are recognised as large

1)

[9 February 2017]

2)

7-hydroxymitragynine

174418-82-7

E,2S,3S,7aS,12bS)-3-ethyl-1,2,3,4,6,7,7a,12b-octahydro-7a-hydroxy-8-methoxy-α-(methoxymethylene) indolo [2,3-a] quinolizine-2-acetic acid methylester

0.03 g

15 g

3)

mitragynine

6202-22-8

(E)-2-[(2S,3S)-3-ethyl-8-methoxy-1,2,3,4,6,7,12,12b- octahydroindolo[3,2-h]-quinolizin-2-yl]-3- methoxyprop-2-enoic acid methylester

0.03 g

3 g

4)

salvinorin A

83729-01-5

(2S,4aR,6aR,7R,9S,10aS,10bR)-9-(acetyloxy)-2-(furan-3-yl)-6a,10b-dimethyl-4,10-dioxododecahydro-2H-benzo[f]isochromene-7-carboxylate

0.002 g

0.2 g

5)

psilocin, psilotsin

520-53-6

3-[2-dimethylaminoethyl)-1H-indol-4-ol

0.05 g

0.25 g

6)

psilocybin

520-52-5

[3-(2-(dimethylamino)-ethyl)1H-indol-4-yl] dihydrogen phosphate

0.05 g

0.25 g

8.3. Compounds of Other Substances

No.

International non-propriety name of the substance (INN)/trivial name of the substance

CAS No.

Chemical name of the substance

Amount up to which the quantity is recognised as small

Amount from which the quantities are recognised as large

1)

tenocyclidine TCP

21500-98-1

1-(1-(2-thienyl) cyclohexyl)piperidine

0.001 g

1 g

2)

eticyclidine PCE

2201-15-2

N-ethyl-1-phenylcyclohexylamine

0.001 g

1 g

3)

rolicyclidine, PHP, PCPY

2201-39-0

1-(1-phenylcyclohexyl)pyrrolidine

0.001 g

1 g

4)

amineptine

57574-09-1

7-[(10,11-dihydro-5H-dibenzo[a,d]-cyclohepten-5-yl)amino]heptanoic acid

0.4 g

2.8 g

5)

cathine

492-39-7

(1S,2S)-2-amino-1phenylpropan-1-ol

0.03 g

10 g

6)

CRA-13

432047-72-8

1-naphthyl[4-(pentyloxy)-1-naphthyl]methanone

0.003 g

1 g

7)

dichloropane

146725-34-0

Methyl-3-(3,4-dichloropheny)-8-azabicyclo[3.2.1]octane-4-carboxylate

0.2 g

10 g

8.4. Plant Products with Psychotropic Effect

No.

Product name

Amount up to which the quantity is recognised as small

Amount from which the quantities are recognised as large

1)

catha edulis

100 g

10 kg

2)

leonotis leonurus    

a)

dried

1 g

100 g

b)

undried

5 g

1 kg

3)

mitragyna speciosa (kratom)

1 g

100 g

4)

nymphaea caerulea    

a)

dried

1 g

100 g

b)

undried

5 g

1 kg

5)

salvia divinorum

1 g

100 g

6)

ephedra plant, dried

100 g

1 kg

7)

psychodelic mushrooms    

a)

dried

0.5 g

5 g

b)

undried

5g

100g

8.5. Psychotropic Substances Corresponding to the Description

No.

Name of substance

Amount up to which the quantity is recognised as small

Amount from which the quantities are recognised as large

1)

2,5-dimethoxyphenyl-ethanamine

2,5-dimethoxyphenyl-ethanamine or any compound derived from 2-(2,5-dimethoxyphenyl)ethanamine:

a) by replacing hydrogen atom(s) on the benzene ring with one or several identical or different substitutes or substitutes, which form a cyclic structure supplementing the benzene ring;

b) by replacing hydrogen atom(s) in an ethylene group with one or several alkyl groups;

c) by replacing one or two hydrogen atoms at the nitrogen atom with a replaced or not-replaced alkyl group or by including nitrogen atom in the cycle;

d) in any of the abovementioned compounds by replacing a hydrogen atom at the nitrogen atom, if it is free, with a not-replaced or replaced hydroxyl group or an acyl group

0.02 g

2 g

2)

3,4-methylenedioxyphenethylamines

3,4-methylenedioxyphenethylamine and any compound derived from 2-(3,4-methylenedioxyphenethyl)ethanamine:

a) by replacing hydrogen atom(s) on the benzene ring with one or several identical or different substitutes or substitutes, which form a cyclic structure supplementing the benzene ring;

b) by replacing hydrogen atom(s) in an ethylene group with one or several alkyl groups;

c) by replacing one or two hydrogen atoms at the nitrogen atom with a replaced or not-replaced alkyl group or by including nitrogen atom in the cycle;

d) in any of the abovementioned compounds by replacing a hydrogen atom at the nitrogen atom, if it is free, with a not-replaced or replaced hydroxyl group or an acyl group

0.02 g

1 g

3)

Amphetamines

1-phenylpropan-2-amine, its enantiomers and any compound derived from them:

a) by not replacing or by replacing one or two hydrogen atoms at the nitrogen atom with not-replaced or replaced alkyl group or by including a nitrogen atom in the cycle;

b) by changing the benzene ring in the compounds referred to in Clause "a" with another cyclic structure, different from the benzene ring, which may be replaced;

c) by replacing hydrogen atoms on the benzene ring of the compounds referred to in Clause "a" with one or several identical or different substitutes or substitutes, which form a cyclic structure supplementing the benzene ring;

d) by replacing one or several hydrogen atoms of a propyl group in any of the abovementioned compounds with a not-replaced or replaced alkyl group or substitutes which form a benzene ring or a cyclic structure supplementing the cyclic structure referred to in Clause "b";

e) in any of the abovementioned compounds by replacing a hydrogen atom at the nitrogen atom, if it is free, with a not-replaced or replaced hydroxyl group or an acyl group

0.02 g

2 g

4)

2-aminoindanes

2-aminoindane or any compound derived from 2-aminoindane:

a) by replacing hydrogen atoms on the benzene ring with one or several identical or different substitutes or substitutes, which form a cyclic structure supplementing the benzene ring;

b) by replacing one or two amino group hydrogen atoms with a not-replaced or replaced alkyl group or by including a nitrogen atom in the cycle

0.02 g

2 g

5)

Cyclic derivatives of 2-(2,5-dimethoxyphenyl)ethanamine

Any compound derived from 2-(2,5-dimethoxyphenyl)ethanamine:

a) in the condition 4 of hydrogen atoms by replacing with alkyl group, haloalkane group or halogen atom;

b) in addition by replacing hydrogen atom of one hydroxyl group with alkylen group or alkenylen group formed by cycle of 5 or 6 members with the benzene ring in ortho-condition;

c) in addition by replacing hydrogen atom of a second hydroxyl group with alkylen group or alkenylen group formed by cycle of 5 or 6 members with the benzene ring in ortho-condition, or methyl group;

d) in addition by not replacing or by replacing one or two amino group hydrogen atoms or by including a nitrogen atom in the cycle;

e) in addition by not replacing or by replacing one or several ethylene group hydrogen atoms with a not-replaced or replaced alkyl group

0.003 g

1 g

6)

Cathinones    

a)

2-amino-1-phenylpropan-1-one and any compound derived from 2-amino-1-phenylpropan-1-one:

a) by not replacing or by replacing one or two hydrogen atoms at the nitrogen atom with not-replaced or replaced alkyl or alkoxy group or by including a nitrogen atom in the cycle;

b) by not replacing or by replacing one or two hydrogen atoms in propanone condition 3 with a not-replaced or replaced alkyl group or alkoxy group or amino group;

c) by changing the benzene ring in the compounds referred to in Clause "a" or "b" with another cyclic structure, different from the benzene ring, which may be replaced;

d) by replacing hydrogen atoms on the benzene ring in any of the compounds referred to in Clause "a" or "b" with one or several identical or different substitutes or substitutes, which form a cyclic structure supplementing the benzene ring;

e) derivatives of any of the abovementioned compound carbonyl group or amino group, or both

0.02 g

3 g

b)

self-made preparation from ephedrine containing ephedrone

1 ml

50 ml

7)

Piperazines

Any compound derived from piperazine:

a) by replacing a hydrogen atom at one nitrogen atom with a not-replaced or replaced phenyl group, not-replaced or replaced benzyl group or cyclohexyl group;

b) by not replacing or replacing the hydrogen atom at a second nitrogen atom with a not-replaced or replaced methyl group

0.02 g

1 g

8)

Tryptamines and beta-(benzofuran-3-yl)ethanamines

Any derivative of beta-(indol-3-yl)ethanamine or beta-(benzofuran-3-yl)ethanamine (except for serotonin, sumatriptan and zolmitriptan) which contains at least one substitute from rows "a", "b" and "c":

a) where hydrogen atom(s) on the benzene ring has (have) been replaced with one or several identical or different substitutes or substitutes, which form a cyclic structure supplementing the benzene ring;

b) where hydrogen atoms in the ethylene group have been replaced with a not-replaced or replaced alkyl group;

c) where one or two hydrogen atoms in the amino group have been replaced with a not-replaced or replaced alkyl group, or a nitrogen atom has been included in the cycle

0.02 g

1 g

9)

1-arylcyclohexylamines and (1-arylcyclohexyl)methanamine

1-arylcyclohexylamines (except for ketamine) and (1-arylcyclohexyl)methanamine where the aryl group is a not-replaced or replaced benzene or thiophene cycle, one or two hydrogen atoms in the amino group have been replaced with a not-replaced or replaced alkyl group, or a nitrogen atom has been included in the cycle, and the cyclohexane cycle is not replaced or replaced with a carbonyl group, hydroxy group, alkoxy group or alkyl group

0.001 g

1 g

10)

Dibenzopyrans

Compounds derived from cannabinol (except for cannabidiol) modified on the ring A, replaced on the ring B, their homologues with different number of carbon atoms in substitute condition 3, cis-, trans- and optical isomers thereof, as well as their derivatives of hydroxyl group and halogen derivatives

0.003 g

1 g

11)

Cyclohexylphenols

Any compound derived from 2-(3-hydroxycyclohexyl)phenol:

a) by replacing hydrogen atom in condition 5 of phenol cycle;

b) in addition by not replacing or by replacing one or several hydrogen atoms in the cyclohexyl group

0.003 g

1 g

12)

Naphthylideneindenes and naphthylmethylindenes

Any compound derived from 1-naphthylideneindene or 1-naphthylmethylindene:

a) by not replacing or by replacing a hydrogen atom at indene C3 atom;

b) in addition to the compounds referred to in Clause "a" by not replacing or by replacing one or several hydrogen atoms in the naphthyl group;

c) in addition by not replacing or by replacing in the compounds referred to in Clause "a" or "b", or both, one or several hydrogen atoms in the indene cycle

0.003 g

1 g

13)

Naphthylmethylindoles

Any compound derived from (indol-3-yl)(naphthyl-1)methane:

a) by not replacing or by replacing a hydrogen atom at the indole nitrogen atom;

b) in addition to the compounds referred to in Clause "a" by not replacing or by replacing one or several hydrogen atoms in the naphthyl group;

c) in addition by not replacing or by replacing in the compounds referred to in Clause "a" or "b", or both, one or several hydrogen atoms in indole cycle

0.003 g

1 g

14)

Napthoylpyrroles

Any compound derived from 3-(1-naphthoyl)pyrrole:

a) by not replacing or by replacing a hydrogen atom at the pyrrole nitrogen atom;

b) in addition to the compounds referred to in Clause "a" by not replacing or by replacing one or several hydrogen atoms in pyrrole cycle;

c) in addition by not replacing or by replacing in the compounds referred to in Clause "a" or "b", or both, one or several hydrogen atoms in the naphthoyl group

0.003 g

1 g

15)

[26 September 2019]

16)

Benzimidazoles

Any compound derived from benzimidazole:

a) by replacing a hydrogen atom at the nitrogen atom with a not-replaced or replaced alkyl group or a not-replaced or replaced aroyl group;

b) in addition by replacing a hydrogen atom at the nitrogen atom of the imidazole cycle with a not-replaced or replaced (hetero)aryl group or a not-replaced or replaced aroyl group;

c) in addition by not replacing or replacing hydrogen atoms on the benzene ring of benzimidazole

0.003 g

1 g

17)

Diphenylethylamines

1,2-diphenylethan-1-amine, its enantiomers and any compound derived from them:

a) by not replacing or replacing hydrogen atoms on one or both benzene rings with one or several identical or different substitutes;

b) in addition in the compounds referred to in Clause "a" by not replacing or by replacing one or both hydrogen atoms of the amino group with a not-replaced or replaced alkyl group or by including it in the cycle;

c) in addition in the compounds referred to in Clause "b" by replacing one carbon atom on one or both benzene rings with a nitrogen atom

0.001 g

0.1 g

18)

Derivatives of carbazole-3-carbonyl

Derivatives of carbazole-3-carbonyl that have been replaced at the carbazole ring in nitrogen atom condition 1 with a not-replaced or replaced alkyl group

and condition 3 at carbonyl group is replaced with:

• a not-replaced or replaced alkyl group, cycloalkyl group;

• a not-replaced or replaced aromatic or heteroaromatic cycle;

• a not-replaced or replaced alkoxy group, aryloxy group, heteryloxy group;

• a replaced amino group

and any of the abovementioned compounds that has been additionally replaced in the carbazole cycle

0.003 g

1 g

19)

Derivatives of pyrazole-3-carbonyl

Derivatives of pyrazole-3-carbonyl, which in condition 3 at carbonyl group are replaced with:

• a not-replaced or replaced alkyl group or a cycloalkyl group,

• a not-replaced or replaced aromatic or heteroaromatic cycle,

• a not-replaced or replaced alkoxy group, aryloxy group, heteryloxy group,

• a replaced amino group

and in pyrazole cycle conditions 1 and 4 (one or both) not replaced or replaced with not-replaced or replaced alkyl groups or aryl groups and in condition 5 replaced with a not-replaced or replaced aryl group

0.003 g

1 g

20)

Derivatives of pyrazole-5-carbonyl

Derivatives of pyrazole-5-carbonyl, which in condition 5 at carbonyl group are replaced with:

• a not-replaced or replaced alkyl group or a cycloalkyl group,

• a not-replaced or replaced aromatic or heteroaromatic cycle,

• a not-replaced or replaced alkoxy group, aryloxy group, heteryloxy group,

• a replaced amino group

and in pyrazole cycle conditions 1 and 4 (one or both) not replaced or replaced with not-replaced or replaced alkyl groups or aryl groups and in condition 3 replaced with a not-replaced or replaced aryl group

0.003 g

1 g

21)

2-phenylmorpholines

2-phenylmorpholine, its enantiomers and any compound derived from them:

a) by changing the benzene ring with a thiophene or pyridine ring;

b) by changing the morpholine cycle with a thiomorpholine cycle;

c) by replacing one or several hydrogen atoms in the benzene, thiophene or pyridine ring with a not-replaced or replaced alkyl group, alkoxy group, amido group, amino group, sulfonyl group or substitutes which create a cyclic structure supplementing the benzene, thiophene or pyridine ring;

d) by replacing one or several hydrogen atoms in the benzene, thiophene or pyridine ring with a hydroxy group or halogen atom;

e) by replacing one or several hydrogen atoms in the morpholine or thiomorpholine cycle with a hydroxy group, nitroso group, carbonyl group or not-replaced or replaced alkyl group

0.1 g

5 g

22)

Lysergamides (or amides of lysergic acid)

4,6,6a,7,8,9-hexahydroindol[4,3-fg]quinoline-9-carboxamide (except for ergometrine, ergotamine, methylergometrine, methysergide), its enantiomers and any compound derived from them:

a) by not replacing or by replacing one or two hydrogen atoms at the nitrogen atom in the amido group with not-replaced or replaced alkyl group(s) or with substitutes which include the nitrogen atom in the cycle;

b) by not replacing or by replacing the hydrogen atom at the nitrogen atom in the hydrogenated quinoline cycle with a not-replaced or replaced alkyl group;

c) by not replacing or by replacing the hydrogen atom at the nitrogen atom in the indoline cycle with a not-replaced or replaced alkyl group or acyl group

0.001 g

0.002 g

23)

Indole-2-one-3-hydrazinecarbonyl derivatives

Indole-2-one-3-hydrazinecarbonyl derivatives, which are replaced at the nitrogen atom of the indole-2-one cycle with a not-replaced or replaced alkyl group, and in condition 3 are replaced at carbonyl group with:

• a not-replaced or replaced alkyl group or a cycloalkyl group,

• a not-replaced or replaced aromatic or heteroaromatic cycle,

• a not-replaced or replaced alkoxy group, aryloxy group, heteryloxy group,

• a replaced amino group,

and any of the abovementioned compounds where the hydrogen atom of the hydrazine group is replaced with an alkyl group,

or replaced in the indole-2-one cycle

0.001 g

0.002 g

24)

Gamma-carboline-1-one

Any compound which is derived from 2,5-dihydro-1H-pyrido[4,3-b]indole-1-one:

a) by replacing the hydrogen atom in condition 5 with a not-replaced or replaced alkyl group or cycloalkyl group;

b) by replacing the hydrogen atom in condition 2 with a not-replaced or replaced alkyl group or cycloalkyl group, not-replaced or replaced aromatic or heteroaromatic cycle,

and any of the abovementioned compounds that has been additionally replaced in the carboline cycle

0.003 g

1 g

25)

[26 September 2019]

26)

8-quinolyl-3-(1-piperidylsulfonyl) benzoates

8-quinolyl-3-(1-piperidylsulfonyl) benzoate and any compound derived from it by replacing one or several hydrogen atoms on quinoline, benzene or piperidine ring with one or several identical or different halogen atoms, alkyl groups, hydroxy groups or alkoxy groups

0.003 g

1 g

8.6. Mixture of Plants, Compressed Mass, Liquid, Mixture of Substances, Impregnated Paper Containing any Quantity of the Substances Referred to in Chapter II, Paragraph 7.1, Paragraph 8.3, Sub-paragraph 6, and Paragraph 8.5 of this Annex

No.

Type of mixture

Amount up to which the quantity is recognised as small

Amount from which the quantities are recognised as large

1)

dried (plant mixture)

1 g

100 g

2)

undried (plant mixture)

5 g

1 kg

3)

compressed mass

0.1 g

50 g

4)

liquid

1 ml

50 ml

5)

mixture of substances that contains the abovementioned substance that is not separable from the total quantity of the mixture of substances

1 g

50 g

6)

impregnated paper (tab)

3 items

10 items

7)

mixture of substances that contains any quantity of the substance referred to in Paragraph 7.1, Sub-paragraph 2

0.001 g

1 g

III. Substances Included in Schedule II
(very dangerous narcotic substances and equivalent psychotropic substances permitted for medical and scientific purposes)

10. Substances classified in conformity with Schedule I and II of the Single Convention on Narcotic Drugs of 30 March 1961 and amendments thereto made in accordance with the 1972 protocol amending the Single Convention on Narcotic Drugs of 30 March 1961:

No.

Name of substance

CAS No.

Amount up to which the quantity is recognised as small

Amount from which the quantities are recognised as large

1)

Acetyldihydrocodeine

3861-72-1

0.2 g

10 g

2)

Acetylmethadol

509-74-0

0.2 g

10 g

3)

Alfentanil

71195-58-9

0.2 g

10 g

4)

Allylprodine

25384-17-2

0.2 g

10 g

5)

Alphameprodine

468-51-9

0.2 g

10 g

6)

Alphamethadol

17199-54-1

0.2 g

10 g

7)

Alphaprodine

77-20-3

0.2 g

10 g

8)

Anileridine

144-14-9

0.2 g

10 g

9)

Benzethidine

3691-78-9

0.2 g

10 g

10)

Benzylmorphine

14297-87-1

0.2 g

10 g

11)

Betacetylmethadol

17199-59-6

0.2 g

10 g

12)

Betameprodine

468-50-8

0.2 g

10 g

13)

Betamethadol

17199-55-2

0.2 g

10 g

14)

Betaprodine

468-59-7

0.2 g

10 g

15)

Benzitramide

15301-48-1

0.2 g

10 g

16)

Dextromoramide

357-56-2

0.2 g

10 g

17)

Dextropropoxyphene

469-62-5

0.2 g

10 g

18)

Diampromide

552-25-0

0.2 g

10 g

19)

Diethylthiambutene

86-14-6

0.2 g

10 g

20)

Difenoxin

28782-42-5

0.2 g

10 g

21)

Dihydrocodeine

125-28-0

0.2 g

10 g

22)

Dihydromorphine

509-60-4

0.2 g

10 g

23)

Dimenoxadol

509-78-4

0.2 g

10 g

24)

Dimepheptanol

545-90-4

0.2 g

10 g

25)

Dimethylthiambutene

524-84-5

0.2 g

10 g

26)

Dioxaphetyl butyrate

467-86-7

0.2 g

10 g

27)

Diphenoxylate

915-30-0

0.2 g

10 g

28)

Dipipanone

467-83-4

0.2 g

10 g

29)

Drotebanol

3176-03-2

0.2 g

10 g

30)

Ecgonine and its derivatives

481-37-8

0.2 g

10 g

31)

Ethylmethylthiambutene

441-61-2

0.2 g

10 g

32)

Ethylmorphine

76-58-4

0.02 g

10 g

33)

Etoxeridine

469-82-9

0.2 g

10 g

34)

Etonitazene

911-65-9

0.2 g

10 g

35)

Phenadoxone

467-84-5

0.2 g

10 g

36)

Phenampromide

129-83-9

0.2 g

10 g

37)

Phenazocine

127-35-5

0.2 g

10 g

38)

Phenomorphan

468-07-5

0.2 g

10 g

39)

Phenoperidine

562-26-5

0.2 g

10 g

40)

Fentanyl

437-38-7

0.001 g

1 g

41)

Pholcodine

509-67-1

0.2 g

10 g

42)

Furethidine

2385-81-1

0.2 g

10 g

43)

Hydrocodone

125-29-1

0.2 g

10 g

44)

Hydromorphinol

2183-56-4

0.2 g

10 g

45)

Hydromorphone

466-99-9

0.2 g

10 g

46)

Hydroxypethidine

468-56-4

0.2 g

10 g

47)

Isomethadone

466-40-0

0.2 g

10 g

48)

Ketobemidone

469-79-4

0.1 g

1 g

49)

Clonitazene

3861-76-5

0.2 g

10 g

50)

Codeine

76-57-3

0.2 g

10 g

51)

Codoxime

7125-76-0

0.2 g

10 g

52)

Cocaine

50-36-2

0,01 g

5 g

53)

Levophenacylmorphan

10061-32-2

0.2 g

10 g

54)

Levomethorphan

125-70-2

0.1 g

10 g

55)

Levomoramide

5666-11-5

0.2 g

10 g

56)

Levorphanol

77-07-6

0.2 g

10 g

57)

Methadone

76-99-3

0.01 g

10 g

58)

Methadone intermediate products

125-79-1

0.2 g

10 g

59)

Metazocine

3734-52-9

0.2 g

10 g

60)

Methyldesorphine

16008-36-9

0.2 g

10 g

61)

Methyldihydromorphine

509-56-8

0.2 g

10 g

62)

Metopon

143-52-2

0.2 g

10 g

63)

Moramide intermediate product

3626-55-9

0.2 g

10 g

64)

Morpheridine

469-81-8

0.2 g

10 g

65)

Morphine

57-27-2

0.01 g

10 g

66)

Morphine methobromide

125-23-5

0.2 g

10 g

67)

Morphine-N-oxide

639-46-3

0.2 g

10 g

68)

Myrophine

467-18-5

0.2 g

10 g

69)

Nicocodine

3688-66-2

0.2 g

10 g

70)

Nicodicodine

808-24-2

0.2 g

10 g

71)

Nicomorphine

639-48-5

0.2 g

10 g

72)

Noracymethadol

1477-39-0

0.2 g

10 g

73)

Norcodeine

467-15-2

0.2 g

10 g

74)

Norlevorphanol

1531-12-0

0.2 g

10 g

75)

Normethadone

467-85-6

0.2 g

10 g

76)

Normorphine

466-97-7

0.2 g

10 g

77)

Norpipanone

561-48-8

0.2 g

10 g

78)

Oxycodone

76-42-6

0.2 g

10 g

79)

Oxymorphone

76-41-5

0.2 g

10 g

80)

Opium

not determined

0.1 g

10 g

81)

Pethidine

57-42-1

0.2 g

10 g

82)

Pethidine intermediate product A

3627-62-1

0.2 g

10 g

83)

Pethidine intermediate product B

77-17-8

0.2 g

10 g

84)

Pethidine intermediate product C

3627-48-3

0.2 g

10 g

85)

Piminodine

13495-09-5

0.2 g

10 g

86)

Piritramide

302-41-0

0.1 g

5 g

87)

Proheptazine

77-14-5

0.2 g

10 g

88)

Properidine

561-76-2

0.2 g

10 g

89)

Propiram

15686-91-6

0.2 g

10 g

90)

Racemethorphan

510-53-2

0.2 g

10 g

91)

Racemoramide

545-59-5

0.2 g

10 g

92)

Racemorphan

297-90-5

0.2 g

10 g

93)

Sufentanil

56030-54-7

0.001 g

1 g

94)

Thebacon

466-90-0

0.2 g

10 g

95)

Thebaine

115-37-7

0.2 g

10 g

96)

Tilidine

20380-58-9

0.2 g

10 g

97)

Trimeperidine (Promedol)

64-39-1

0.03 g

10 g

98)

Dihydroethorphine

14357-76-7

0.2 g

10 g

99)

Remifentanil

132875-61-7

0.2 g

10 g

100)

4-anilinopiperidine

23056-29-3

0.6 g

10 g

11. Substances classified in conformity with Schedule II of the Convention on Psychotropic Substances of 21 February 1971:

No.

Name of substance

CAS No.

Amount up to which the quantity is recognised as small

Amount from which the quantities are recognised as large

1) Zipeprol

34758-83-3

0.2 g

10 g

2) Phencyclidine

77-10-1

0.001 g

1 g

3) Phenmetrazine

134-49-6

0.1 g

5 g

4) Mecloqualone

340-57-8

0.2 g

10 g

5) Methaqualone

72-44-6

0.05 g

5 g

6) Methylphenidate

113-45-1

0.2 g

10 g

7) Secobarbital

76-73-3

0.2 g

10 g

8) Dronabinol (delta-9-tetrahydrocannabinol and its stereochemical variations)

1972-08-3 (CAS No. indicated for the substance "dronabinol")

0.2 g

10 g

9) Gamma-hydroxybutyric acid (GHB)

591-81-1

0.6 g

10 g

10) methylmorphenate

231299-92-6

0.2 g

10 g

12) Substances classified in conformity with Schedule III of the Convention on Psychotropic Substances of 21 February 1971:

No.

Name of substance

CAS No.

Amount up to which the quantity is recognised as small

Amount from which the quantities are recognised as large

1) Amobarbital

57-43-2

0.1 g

10 g

2) Buprenorphine

52485-79-7

0.001 g

1 g

3) Butalbital

77-26-9

0.1 g

10 g

4) Cyclobarbital

52-31-3

0.1 g

10 g

5) [6 December 2018]
6) Flunitrazepam

1622-62-4

0.01 g

5 g

7) Glutethimide

77-21-4

1.5 g

15 g

8) Pentazocine

359-83-1

0.03 g

5 g

9) Pentobarbital

76-74-4

0.1 g

10 g

10) [6 December 2018]

12.1 Narcotic substances which endanger health if illegally trafficked and used:

No.

Name of substance

CAS No.

Amount up to which the quantity is recognised as small

Amount from which the quantities are recognised as large

1) Tapendatol

175591-09-0

0.1 g

10 g

2) Hexobarbital

56-29-1

0.1 g

10 g

12.2 Mixture of plants, compressed mass, liquid, mixture of substances, impregnated paper which contains any quantity of the substances referred to in Chapter III of this Annex

No.

Type of mixture

Amount up to which the quantity is recognised as small

Amount from which the quantities are recognised as large

1)

dried (plant mixture)

1 g

100 g

2)

undried (plant mixture)

5 g

1 kg

3)

compressed mass

0.1 g

50 g

4)

liquid

1 ml

50 ml

5)

mixture of substances that contains any quantity of the substance referred to in Schedule II and that is not separable from the total quantity

30 g

100 g

6)

impregnated paper (tab)

3 items

10 items

IV. Substances Included in Schedule III (dangerous psychotropic substances which might be abused)

13. Substances classified in conformity with Schedule IV of the Convention on Psychotropic Substances of 21 February 1971:

No.

Name of substance

CAS No.

Amount up to which the quantity is recognised as small

Amount from which the quantities are recognised as large

1) Allobarbital

52-43-7

0.6 g

10 g

2) Alprazolam

28981-97-7

0.001 g

1 g

3) Amfepramone

90-84-6

0.1 g

10 g

4) Aminorex

2207-50-3

0.01 g

5 g

5) Barbital

57-44-3

0.5 g

10 g

6) Benzphetamine

156-08-1

0.6 g

10 g

7) Bromazepam

1812-30-2

0.4 g

10 g

8) Brotizolam

57801-81-7

0.01 g

5 g

9) Butobarbital

77-28-1

0.6 g

10 g

10) Cephedrine

67055-59-8

0.5 g

10 g

11) Trihexiphenidyl

144-11-6

0.01 g

10 g

12) Delorazepam

2894-67-9

0.6 g

10 g

13) Diazepam

439-14-5

0.1 g

10 g

14) Ephedrine

299-42-3

0.6 g

10 g

15) Estazolam

29975-16-4

0.02 g

10 g

16) Ethchlorvynol

113-18-8

0.6 g

10 g

17) Ethinamate

126-52-3

0.6 g

10 g

18) Ethyl Loflazepate

29177-84-2

0.6 g

10 g

19) Fenatine

139-68-4

0.6 g

10 g

20) Fenazepam

51753-57-2

0.05 g

10 g

21) Fencamphamine

1209-98-9

0.6 g

10 g

22) Phendimetrazine

634-03-7

0.6 g

10 g

23) Fenobarbital

50-06-6

0.6 g

10 g

24) Fludiazepam

3900-31-0

0.6 g

10 g

25) Flurazepam

17617-23-1

0.6 g

10 g

26) Tofizopam

22345-47-7

0.6 g

10 g

27) Halazepam

23092-17-3

0.05 g

10 g

28) Haloxazolam

59128-97-1

0.6 g

10 g

29) Chlordiazepoxide

58-25-3

0.5 g

10 g

30) Camazepam

36104-80-0

0.6 g

10 g

31) Ketazolam

27223-35-4

0.6 g

10 g

32) Clobazam

22316-47-8

0.6 g

10 g

33) Cloxazolam

24166-13-0

0.6 g

10 g

34) Clonazepam

1622-61-3

0.06 g

5 g

35) Clorazepate

23887-31-2

0.6 g

10 g

36) Clotiazepam

33671-46-4

0.6 g

10 g

37) Lefetamine (SPA)

7262-75-1

0.6 g

10 g

38) Loprazolam

61197-73-7

0.6 g

10 g

39) Lorazepam

846-49-1

0.02 g

5 g

40) Lormetazepam

848-75-9

0.6 g

10 g

41) Mazindol

22232-71-9

0.6 g

10 g

42) Medazepam

2898-12-6

0.5 g

5 g

43) Meprobamate

57-53-4

0.6 g

10 g

44) Methylphenobarbital

115-38-8

0.6 g

10 g

45) Methyprylon

125-64-4

0.6 g

10 g

46) Mesocarb

34262-84-5

0.6 g

10 g

47) Midazolam

59467-70-8

0.6 g

10 g

48) Nimetazepam

2011-67-8

0.6 g

10 g

49) Nitrazepam

146-22-5

0.1 g

10 g

50) Nordazepam

1088-11-5

0.6 g

10 g

51) Oxazepam

604-75-1

0.5 g

10 g

52) Oxazolam

24143-17-7

0.6 g

10 g

53) Pemoline

2152-34-3

0.6 g

10 g

54) Pinazepam

52463-83-9

0.6 g

10 g

55) Pipradrol

467-60-7

0.6 g

10 g

56) Pyrovalerone

3563-49-3

0.6 g

10 g

57) Prazepam

2955-38-6

0.6 g

10 g

58) Pseudoephedrine

90-82-4

0.6 g

10 g

59) Secbutabarbital

125-40-6

0.6 g

10 g

60) Propanidid

1421-14-3

0.5 g

10 g

61) Temazepam

846-50-4

0.5 g

10 g

62) Tetrazepam

10379-14-3

0.6 g

10 g

63) Triazolam

28911-01-5

0.001 g

1 g

64) Vinylbital

2430-49-1

0.6 g

10 g

65) Zolpideme

82626-48-0

0.6 g

10 g

66) Zopiclone

43200-80-2

0.06 g

5 g

67) Tramadol

27203-92-5

0.5 g

6 g

68) derivative of alprazolam triazolbenzophenone

not available

0.001 g

1 g

69) Deschloroetizolam

40054-73-7

0.01 g

5 g

70) Metizolam

40054-68-0

0.01 g

5 g

71) Nitrazolam

28910-99-8

0.001 g

1 g

72) Pyrazolam

39243-02-2

0.001 g

1 g

73) Etizolam

40054-69-1

0.01 g

5 g

13.1 Mixture of plants, compressed mass, liquid, mixture of substances, impregnated paper which contains any quantity of the substances referred to in Chapter IV of this Annex

No.

Type of mixture

Amount up to which the quantity is recognised as small

Amount from which the quantities are recognised as large

1)

dried (plant mixture)

1 g

100 g

2)

undried (plant mixture)

5 g

1 kg

3)

compressed mass

0.1 g

50 g

4)

liquid

1 ml

50 ml

5)

mixture of substances that contains any quantity of the substance referred to in Schedule III and that is not separable from the total quantity

30 g

100 g

6)

impregnated paper (tab)

3 items

10 items

V. Substances Included in Schedule IV (precursors - substances, which may be utilised for unauthorised manufacture of narcotic and psychotropic substances and which are referred to in Annex I to Regulation No 273/2004 of the European Parliament and of the Council of 11 February 2004 on drug precursors and Annex to Regulation No 111/2005 of 22 December 2004 laying down rules for the monitoring of trade between the Community and third countries in drug precursors)

14. Precursors of Category 1:

No.

Name of substance

CAS No.

Amount up to which the quantity is recognised as small

Amount from which the quantities are recognised as large

1) N-acetyl anthranilic acid

89-52-1

50 g

1 kg

2) Ephedrine

299-42-3

0.6 g

10 g

3) Ergometrine

60-79-7

50 g

1 kg

4) Ergotamine

113-15-5

50 g

1 kg

5) 1-phenyl-2-propanone

103-79-7

50 g

1 kg

6) Isosafrole (cis + trans)

120-58-1

50 g

1 kg

7) Lysergic acid

82-58-6

10 g

100 g

8) 3,4-methylenedioxy-phenyl-2-propanone

4676-39-5

50 g

1 kg

9) Norephedrine

14838-15-4

0.6 g

10 g

10) Piperonal

120-57-0

50 g

1 kg

11) Pseudoephedrine

90-82-4

0.6 g

10 g

12) Safrole

94-59-7

50 g

1 kg

13) alpha-phenylacetoacetonitrile

4468-48-8

10 g

100 g

14) (1R,2S)-(-)-chloroephedrine

110925-64-9

0.6 g

10 g

15) (1S,2R)-(+)-chloroephedrine

1384199-95-4

0.6 g

10 g

16) (1S,2S)-(+)-chloropseudoephedrine

73393-61-0

0.6 g

10 g

17) (1R,2R)-(-)-chloropseudoephedrine

771434-80-1

0.6 g

10 g

18) [26 September 2019]
19) N-phenethyl-4-piperidinone (NPP)

39742-60-4

0.6 g

10 g

20) 4-anilino-N-phenethylpiperidine (ANPP)

21409-26-7

0.6 g

10 g

15. Precursors of Category II:

No.

Name of substance

CAS No.

Amount up to which the quantity is recognised as small

Amount from which the quantities are recognised as large

1) Anthranilic acid

118-92-3

1 kg

5 kg

2) Acetic anhydride

108-24-7

1 kg

5 kg

3) Phenylacetic acid

103-82-2

1 kg

5 kg

4) [6 December 2018]
5) Potassium permanganate

7722-64-7

1 kg

5 kg

6) Piperidine

110-89-4

1 kg

5 kg

16. Precursors of Category III:

No.

Name of substance

CAS No.

Amount up to which the quantity is recognised as small

Amount from which the quantities are recognised as large

1) acetone

67-64-1

5 kg

20 kg

2) ethyl ether

60-29-7

5 kg

20 kg

3) Methyl ethyl ketone (MEK)

78-93-3

5 kg

20 kg

4) Hydrochloric acid

7647-01-0

5 kg

20 kg

5) Sulphuric acid

7664-93-9

5 kg

20 kg

6) Toluene

108-88-3

5 kg

20 kg

 

Law On the Procedures for the Coming into Force and Application of the Criminal Law
Annex 3

Criteria for the Specification of the Seriousness Level of Bodily Injury

[24 October 2002; 21 October 2010; 25 April 2013; 8 June 2017]

I. Evaluation of Bodily Injury

1. Bodily injury is an anatomical injury or functional disorders to the tissues, organs or systems of a human organism that have been caused as a result of mechanical, thermal, electrical, acoustic, radiation, chemical, biological or other effects. Also mental disorders or traumas that have been caused as a result of mental effects or the abovementioned effects shall be equivalent to bodily injury.

2. The seriousness level of bodily injury and the causal link thereof shall be determined by a forensic expert (hereinafter - the expert).

3. [8 June 2017]

4. It is mandatory for an expert to indicate in his or her opinion the following regarding the bodily injury:

1) the medical or psychological nature;

2) the possible cause;

3) the time it was caused;

4) the seriousness level.

5. In determining the seriousness level of a bodily injury, the expert shall be guided only by objective data, and not take into account all the health disorder time if such is not based upon the nature of the bodily injury.

6. The aggravation of a previous illness or health disorder after committing of bodily injury, as well as bodily injury complications, which have been caused by circumstances of an incident, the specific characteristics of the individual organism or as a result of medical treatment errors shall not be the basis for raising the seriousness level of a bodily injury. In such cases the expert shall indicate in the opinion that the health condition has deteriorated or the nature of complications and the causal link thereof with the abovementioned circumstances.

7. Traumatic changes in artificial joints - knees, hips and other joints or other implanted artificial objects shall not be evaluated as bodily injury. In such cases the body tissue injuries shall be evaluated on the basis of the real health disorder and the length thereof.

8. Injury to viable transplants - fingers, palms, nose, ear conches, kidneys and other transplanted organs shall be evaluated according to normal bodily injury evaluation criteria.

9. In determining the seriousness level of bodily injury to children or persons who are older than 60 years of age, an expert shall take into account only the medical nature of the bodily injury irrespective of the duration of medical treatment.

10. [8 June 2017]

11. An opinion of the seriousness level of a bodily injury shall be justified by the expert with medical or other objective data. If the bodily injury corresponds to the features of various seriousness levels, the expert shall evaluate each bodily injury separately starting with the most serious, or evaluate the bodily injury in general according to the most serious. Bodily injury caused at various times shall be evaluated separately. The expert shall substantiate the seriousness level of a mental disorder or mental trauma with data obtained from the case materials, and also from data obtained during psychiatric or psychological evaluation.

12. An expert may give an opinion on the seriousness level of a bodily injury prior to the completion of medical treatment if the seriousness and consequences of the bodily injury, on the basis of objective data, does not cause doubts. In the case where the consequences of bodily injury cannot be clearly foreseen, the expert shall postpone the evaluation of the seriousness of the bodily injury by requesting the necessary materials from the person directing the proceedings.

13. The amount of the ongoing health disorder caused by the bodily injury shall be determined during a forensic medical examination and expressed in percentage.

II. Serious Bodily Injuries

14. Serious bodily injuries are such bodily injuries, which have been the reason for:

1) a threat to life (bodily injuries dangerous to life);

2) loss of organ or the functions thereof;

3) ongoing health disorder (the ongoing health disorder determined during the forensic medical examination exceeds the amount of 30 per cent);

4) termination of pregnancy;

5) irreparable facial disfigurement;

6) mental disorder with a chronic course or mental trauma with permanent consequences which affects the social adaptation of a person significantly.

15. Dangerous to life are bodily injuries, which at the moment of being committed or at a later time threaten the life of the victim. Dangerous to life are:

1) bodily injuries, which penetrate the cranial, chest and abdominal cavity or spinal cord, also without damage to internal organs;

2) closed and open fractures of cranial vault or basilar bones, except for isolated outer calvarial table fractures or isolated fractures of cranial bone processes outside the cranial cavity if there are no other dangerous to life intracranial damage;

3) damage to large blood vessels - aorta, common, external and internal carotid arteries, lower collarbone, armpit, humerus, pelvis, thigh, hamstring arteries or corresponding types of blood vessels;

4) the place of fractures to long tubular bones - open diaphyseal fractures of humerus, femur, tibia - is connected to the outer environment through the wound;

5) fractures of the cervical vertebrae (including fractures to tooth-shaped projection on the second vertebra), fractures-sprains or sprains, except for isolated vertebra projection fractures;

6) one or more chest or waist vertebra fractures or fractures-sprains with disturbance of the functions of spinal cord or clinically manifested shock signs;

7) pelvic bones' fractures with damage to internal organs or clinically manifested shock, or acute dangerous to life loss of blood, and also pelvic ring fractures that have caused the deformation and instability thereof;

8) damage to the cerebrum and the cover thereof with symptoms, which attest to serious cerebral coma (3-8 points on the Glasgow Coma Scale), damage to the trunk or manifested cerebral oedema, intracranial haemorrhage or post-traumatic hygroma, which causes dangerous cerebral displacement and compression;

9) damage to internal organs, as well as endocrine glands with symptoms which attest to danger to life;

10) other damage, which has caused some dangerous to life circumstances:

a) coma,

b) clinically manifested shock,

c) massive loss of blood,

d) respiratory and blood circulation incompetence syndrome,

e) liver or kidney incompetence syndrome,

f) acute hormonal dysfunction syndrome,

g) septic condition in the course of traumatic illness,

h) regional and organ blood circulation incompetence syndrome;

11) penetrating damage to the throat, larynx, windpipe and oesophagus, as well as closed fractures to the larynx and windpipe cartilage with clinically manifested shock and respiratory problems;

12) compression of throat organs with manifest asphyxiation phenomenon complex: cerebral blood circulation disturbance, unconsciousness, amnesia, and other;

13) II a level burns which cover more than 20 per cent of the body surface; IIb and III level burns which cover not less than 10 per cent of the body surface; respiratory tract burns with manifest oedema and glottal narrowing which have caused respiratory problems dangerous to life;

14) multiple bone fractures:

a) closed fractures to two or several long tubular bones - femur, tibia, humerus - or also any closed complex tubular bones fractures together with fractures to two or several pelvic bones, or fractures to the body or arch of two or several thoracic or lumber vertebrae,

b) fractures to several ribs either on one side or both sides (not less than five) along two or more lines if they have caused rib cage deformation or instability or also significant pulmonary ventilation disturbances with accumulation of air and blood in the pleural cavity and pulmonary deflation.

16. Loss of organ or the function thereof is:

1) complete loss of vision in both eyes (incurable blindness), as well as such a condition when the victim cannot count fingers at a distance of two metres and closer, or other serious visual disturbance, which conforms to a Group 1 disability for eyes; complete loss of vision in one eye shall be evaluated on the basis of the feature - ongoing health disorder in the amount of more than 30 per cent (possible correction of visual disturbance with optical glasses shall not be taken into account); the removal of the blind eyeball causes irreparable changes to the face - facial asymmetry;

2) complete loss of hearing in both ears (incurable deafness), as well as a condition when the victim cannot hear a loud voice at a distance of 3-5 centimetres from auricle; loss of hearing in one ear shall be evaluated on the basis of the feature - ongoing health disorder in the amount of more than 30 per cent;

3) loss of an organ or the function thereof which is expressed as:

a) loss of speech by which shall be understood such an incurable condition when the victim is unable to express his or her thoughts to others with understandable articulated sounds,

b) anatomical loss of hands, legs, also separation of palms and soles from the body, or loss of other organs or the functions thereof - paralysis or other condition of inactivity,

c) loss of reproductive capacity (the loss of ability to perform sexual intercourse, impregnation and fertilisation capacity, capability to give birth), and also full or partial removal of external genital organs, including full or partial removal of clitoris, labia minora or majora, or infibulation, except for manipulations carried out due to medical indications.

17. An expert shall not qualify damage to the face as disfigurement. The expert shall only determine the medical nature of the bodily injury and the level of seriousness, as well as the fact if the damage is irreparable.

18. [8 June 2017]

19. Bodily injury, which has been the reason for the termination of pregnancy irrespective of the pregnancy period, shall be serious bodily harm if only the cause of the termination of pregnancy is not the specific characteristics of the individual organism.

III. Medium Serious and Slight Bodily Injuries

20. Medium serious bodily injuries are the following bodily injuries:

1) isolated fractures to outer calvarial table, fractures to the eye periorbital area of ethmoid bone and isolated fractures to the lateral epicondyle of the occipital bone without danger to life symptoms;

2) fractures to the breastbone, one or several ribs without damage to internal organs;

3) incomplete or uncomplicated fractures to individual tubular bones;

4) fractures to the facial skeleton, except for uncomplicated fracture of nasal bones;

5) fractures to the body or cornicle of the hyoid bone without asphyxiation features;

6) fractures of the larynx cartilage without danger to life symptoms;

7) isolated damage to large joints and ligaments or cartilage of such joints - hip, knee, shoulder sprains, and also sprains of other joints if there is damage to joint capsule or severance of ligaments;

8) trauma of the cerebrum and the cover thereof which causes cognitive loss (9 to 12 points according to the Glasgow Coma Scale) and does not cause dangerous cerebral displacement and compression;

9) long-lasting health disorder exceeding 21 days;

10) ongoing health disorder in the amount of 10-30 per cent;

11) mental disorder or mental trauma affecting the social adaptation of a person on a long-term basis.

21. [8 June 2017]

22. [8 June 2017]

23. Light bodily injuries are bodily injuries that have caused short-term health disorders from 7 to 21 days, or the ongoing health disorder determined during the forensic medical examination is less than in the amount of 10 per cent.

24. [21 October 2010]

25. [21 October 2010]

 

Law On the Procedures for the Coming into Force and Application of the Criminal Law
Annex 4

Property not to be Confiscated for the Convicted Person or his or her Dependants

[25 April 2013]

In determining punishment - confiscation of property - the following property owned by a person shall not be confiscated:

1. Home furnishings, clothing and household items, which are necessary to the convicted person, his or her family and his or her dependants:

1) everyday clothing, footwear and underwear;

2) bedding accessories, nightwear and towels;

3) kitchen and table accessories for everyday use;

4) furniture - one bed and chair per each person, as well as one table and one closet per family;

5) all accessories for children.

2. Food products, which are necessary for the livelihood of the convicted person and his or her family.

3. Money in the amount of minimum monthly salary for the convicted person and each member of his or her family, if the family member is a dependant of the convicted person and he or she does not have other income.

4. Heating fuel, which is necessary for the family for cooking and heating of residential premises.

5. Equipment and tools, which are necessary to the convicted person in order to continue economic or professional activities, except in cases when the person has been recognised as insolvent or the right of the person to a specific occupation has been revoked by a ruling in criminal matter.

6. For persons whose occupation is agriculture - two animals of different genders from each species kept for farming purposes and one beehive, fodder for feeding of the referred to animals until harvesting of new fodder or letting of stock out to pasture, as well as seed and planting material.

7. Pets owned by the convicted person.

8. Dwelling in the ownership or joint ownership of the convicted person, which is the only dwelling of the convicted person and in which he or she resides on everyday basis.

9. Property without material value, confiscation of which would cause losses to the State.

10. Wedding ring.

11. Churches and religious items for the performance of ritual activities.

 


1 The Parliament of the Republic of Latvia

Translation © 2021 Valsts valodas centrs (State Language Centre)

 
Document information
Title: Par Krimināllikuma spēkā stāšanās un piemērošanas kārtību Status:
In force
in force
Issuer: Saeima Type: law Adoption: 15.10.1998.Entry into force: 05.11.1998.Theme: Criminal justicePublication: Latvijas Vēstnesis, 331/332, 04.11.1998.; Latvijas Republikas Saeimas un Ministru Kabineta Ziņotājs, 23, 03.12.1998.
Language:
LVEN
Related documents
  • Amendments
  • Changes legal status of
  • Legal basis of
  • General Findings of the Supreme Court
  • Explanations
  • Books
  • Other related documents
50539
{"selected":{"value":"01.06.2021","content":"<font class='s-1'>01.06.2021.-...<\/font> <font class='s-3'>Sp\u0113k\u0101 eso\u0161\u0101<\/font>"},"data":[{"value":"01.06.2021","iso_value":"2021\/06\/01","content":"<font class='s-1'>01.06.2021.-...<\/font> <font class='s-3'>Sp\u0113k\u0101 eso\u0161\u0101<\/font>"},{"value":"05.11.2020","iso_value":"2020\/11\/05","content":"<font class='s-1'>05.11.2020.-31.05.2021.<\/font> <font class='s-2'>V\u0113sturisk\u0101<\/font>"},{"value":"29.09.2020","iso_value":"2020\/09\/29","content":"<font class='s-1'>29.09.2020.-04.11.2020.<\/font> <font class='s-2'>V\u0113sturisk\u0101<\/font>"},{"value":"06.07.2020","iso_value":"2020\/07\/06","content":"<font class='s-1'>06.07.2020.-28.09.2020.<\/font> <font class='s-2'>V\u0113sturisk\u0101<\/font>"},{"value":"23.11.2019","iso_value":"2019\/11\/23","content":"<font class='s-1'>23.11.2019.-05.07.2020.<\/font> <font class='s-2'>V\u0113sturisk\u0101<\/font>"},{"value":"08.10.2019","iso_value":"2019\/10\/08","content":"<font class='s-1'>08.10.2019.-22.11.2019.<\/font> <font class='s-2'>V\u0113sturisk\u0101<\/font>"},{"value":"10.01.2019","iso_value":"2019\/01\/10","content":"<font class='s-1'>10.01.2019.-07.10.2019.<\/font> <font class='s-2'>V\u0113sturisk\u0101<\/font>"},{"value":"01.01.2018","iso_value":"2018\/01\/01","content":"<font class='s-1'>01.01.2018.-09.01.2019.<\/font> <font class='s-2'>V\u0113sturisk\u0101<\/font>"},{"value":"16.10.2017","iso_value":"2017\/10\/16","content":"<font class='s-1'>16.10.2017.-31.12.2017.<\/font> <font class='s-2'>V\u0113sturisk\u0101<\/font>"},{"value":"17.03.2017","iso_value":"2017\/03\/17","content":"<font class='s-1'>17.03.2017.-15.10.2017.<\/font> <font class='s-2'>V\u0113sturisk\u0101<\/font>"},{"value":"01.05.2016","iso_value":"2016\/05\/01","content":"<font class='s-1'>01.05.2016.-16.03.2017.<\/font> <font class='s-2'>V\u0113sturisk\u0101<\/font>"},{"value":"01.03.2016","iso_value":"2016\/03\/01","content":"<font class='s-1'>01.03.2016.-30.04.2016.<\/font> <font class='s-2'>V\u0113sturisk\u0101<\/font>"},{"value":"03.12.2015","iso_value":"2015\/12\/03","content":"<font class='s-1'>03.12.2015.-29.02.2016.<\/font> <font class='s-2'>V\u0113sturisk\u0101<\/font>"},{"value":"01.06.2015","iso_value":"2015\/06\/01","content":"<font class='s-1'>01.06.2015.-02.12.2015.<\/font> <font class='s-2'>V\u0113sturisk\u0101<\/font>"},{"value":"11.07.2014","iso_value":"2014\/07\/11","content":"<font class='s-1'>11.07.2014.-31.05.2015.<\/font> <font class='s-2'>V\u0113sturisk\u0101<\/font>"},{"value":"16.05.2013","iso_value":"2013\/05\/16","content":"<font class='s-1'>16.05.2013.-10.07.2014.<\/font> <font class='s-2'>V\u0113sturisk\u0101<\/font>"},{"value":"23.02.2013","iso_value":"2013\/02\/23","content":"<font class='s-1'>23.02.2013.-15.05.2013.<\/font> <font class='s-2'>V\u0113sturisk\u0101<\/font>"},{"value":"16.08.2012","iso_value":"2012\/08\/16","content":"<font class='s-1'>16.08.2012.-22.02.2013.<\/font> <font class='s-2'>V\u0113sturisk\u0101<\/font>"},{"value":"01.01.2012","iso_value":"2012\/01\/01","content":"<font class='s-1'>01.01.2012.-15.08.2012.<\/font> <font class='s-2'>V\u0113sturisk\u0101<\/font>"},{"value":"01.01.2011","iso_value":"2011\/01\/01","content":"<font class='s-1'>01.01.2011.-31.12.2011.<\/font> <font class='s-2'>V\u0113sturisk\u0101<\/font>"},{"value":"23.12.2009","iso_value":"2009\/12\/23","content":"<font class='s-1'>23.12.2009.-31.12.2010.<\/font> <font class='s-2'>V\u0113sturisk\u0101<\/font>"},{"value":"01.07.2009","iso_value":"2009\/07\/01","content":"<font class='s-1'>01.07.2009.-22.12.2009.<\/font> <font class='s-2'>V\u0113sturisk\u0101<\/font>"},{"value":"11.06.2008","iso_value":"2008\/06\/11","content":"<font class='s-1'>11.06.2008.-30.06.2009.<\/font> <font class='s-2'>V\u0113sturisk\u0101<\/font>"},{"value":"13.06.2007","iso_value":"2007\/06\/13","content":"<font class='s-1'>13.06.2007.-10.06.2008.<\/font> <font class='s-2'>V\u0113sturisk\u0101<\/font>"},{"value":"24.02.2007","iso_value":"2007\/02\/24","content":"<font class='s-1'>24.02.2007.-12.06.2007.<\/font> <font class='s-2'>V\u0113sturisk\u0101<\/font>"},{"value":"03.01.2003","iso_value":"2003\/01\/03","content":"<font class='s-1'>03.01.2003.-23.02.2007.<\/font> <font class='s-2'>V\u0113sturisk\u0101<\/font>"},{"value":"27.11.2002","iso_value":"2002\/11\/27","content":"<font class='s-1'>27.11.2002.-02.01.2003.<\/font> <font class='s-2'>V\u0113sturisk\u0101<\/font>"},{"value":"12.06.2002","iso_value":"2002\/06\/12","content":"<font class='s-1'>12.06.2002.-26.11.2002.<\/font> <font class='s-2'>V\u0113sturisk\u0101<\/font>"},{"value":"11.07.2000","iso_value":"2000\/07\/11","content":"<font class='s-1'>11.07.2000.-11.06.2002.<\/font> <font class='s-2'>V\u0113sturisk\u0101<\/font>"},{"value":"01.01.2000","iso_value":"2000\/01\/01","content":"<font class='s-1'>01.01.2000.-10.07.2000.<\/font> <font class='s-2'>V\u0113sturisk\u0101<\/font>"},{"value":"26.03.1999","iso_value":"1999\/03\/26","content":"<font class='s-1'>26.03.1999.-31.12.1999.<\/font> <font class='s-2'>V\u0113sturisk\u0101<\/font>"},{"value":"05.11.1998","iso_value":"1998\/11\/05","content":"<font class='s-1'>05.11.1998.-25.03.1999.<\/font> <font class='s-2'>Pamata<\/font>"}]}
01.06.2021
84
0
  • Twitter
  • Facebook
  • Draugiem.lv
 
0
Latvijas Vestnesis, the official publisher
ensures legislative acts systematization
function on this site.
All Likumi.lv content is intended for information purposes.
About Likumi.lv
News archive
Useful links
For feedback
Contacts
Mobile version
Terms of service
Privacy policy
Cookies
Latvijas Vēstnesis "Everyone has the right to know about his or her rights."
Article 90 of the Constitution of the Republic of Latvia
© Official publisher "Latvijas Vēstnesis"
ISO 9001:2015 (quality management system)
ISO 27001:2013 (information security)